An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19. Here, we show that the ribonucleoside analog β-d-N -hydroxycytidine (NHC; EIDD-1931) has broad-spectrum antiviral...
Saved in:
Published in | Science translational medicine Vol. 12; no. 541 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
29.04.2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!